APC and melanoma: Abnormal activation of Wnt/β-catenin signaling, due to loss-of-function mutations in APC or activating mutations in β-catenin has been linked to tumorigenesis in many settings including melanoma, breast, colon and hepatocellular carcinomas [21,23].